Embolization of uterine fibroids.
Since the first description of uterine artery embolization for the treatment of symptomatic fibroids of the uterus in 1994, this minimally invasive procedure has been increasingly performed in many Western countries. The method is characterized by a high technical success rate of about 85%, a highly significant relief of symptoms, and a very low rate of complications that make this method an appealing alternative to classic treatment options of surgical or laparoscopic myomectomy or hysterectomy. These characteristics have made the procedure well accepted by affected women. Nevertheless, indications and potential contraindications have to be evaluated carefully, especially in patients of childbearing age whenever a considerable number of deliveries is reported after uterine fibroid embolization. This article discusses the clinical background, indications and contraindications, angiographic techniques, potential complications and side effects, and the mid-term results known at present.
Helmberger
T K
TK
Department of Clinical Radiology, Klinikum Grosshadern Ludwig-Maximilians-Universität, Marchioninistr. 15, D-81366 Munich, Germany. helmberg@ikra.med.uni-muenchen.de
Jakobs
T F
TF
Reiser
M F
MF
D004621:Embolization, Therapeutic / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D010146:Pain / Q000517:prevention & control; D011247:Pregnancy; D015641:Radiography, Interventional; D014594:Uterine Neoplasms / Q000628:therapy*